Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 02, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Agilent Introduces Next-Generation UV-Vis Diode Array Spectrophotometer
Friday, April 04, 2014
Cary 8454 UV-Vis and optimized software ideal for pharmaceutical and highly regulated industries.

Waters Progenesis QI Marks Next Generation of LC-MS 'Omics Analysis
Friday, April 04, 2014
Company unveiled two new data analysis software packages for proteomics and metabolomics/lipidomics analyses: Progenesis® QI and Progenesis QI for Proteomics at Analytica.

Illumina Expands Product Portfolio
Thursday, April 03, 2014
End-to-end genomics solutions will transform the future of oncology.

Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform
Thursday, April 03, 2014
Expansion to identify novel biomarkers predictive of cancer outcomes.

Autoscribe Updates Matrix Gemini LIMS
Wednesday, April 02, 2014
Enhancement includes new functionality for the ‘runsheet’ function

Accelrys Notebook 5.0 Sets New Standards for Moving from Paper-Based to Digital Laboratories
Wednesday, April 02, 2014
Easy Configuration, Fast Adoption and Improved Productivity Drives Faster Innovation in Today's Science-Driven World

LabWare Releases New Version of LabWare LIMS Solution
Wednesday, April 02, 2014
Significant features include functional as well as performance enhancements.

Genedata Biologics 4.0 Enables Large-scale Design, Synthesis, and Testing of Bispecific Antibodies
Wednesday, April 02, 2014
Integrated biologics data workflow system now supports fully automated, high-throughput next-generation antibody generation and characterization

Northwestern University Adopts DNASTAR Lasergene Software
Tuesday, April 01, 2014
License provides access to software for all faculty, staff, and students of University.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 859
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv